ElleS review

What it is

ElleS, operating as ElleS Inc., is a compounded telehealth service spanning weight loss, hair loss, longevity, TRT, HRT and sexual health. Its longevity line carries a sermorelin injection, an NAD⁺ nasal spray and glutathione; its hormone lines cover clinician-reviewed testosterone therapy for men and oestradiol cream for women; its weight line runs compounded semaglutide and tirzepatide in both injectable and oral-capsule form plus microdose options and Lipo-C, with Registered Dietitian support available. Intake and the patient portal run on CareValidate. It publishes a full legal suite — terms of service, privacy policy, privacy practices and medical consent.

How it works

Intake-gated from the first click. The public site describes categories rather than products; the catalogue, the doses and the prices all surface only after you complete the CareValidate intake, at which point a licensed clinician determines whether treatment is appropriate. For a multi-vertical service that structure has an internal logic — what you are eligible for genuinely does depend on your answers — but it also means you cannot compare ElleS against anything before committing time and personal health information to it. The specific disclosure gaps are worth listing plainly, because they compound: the compounding pharmacy is described only as licensed US facilities and never named, no state-availability list is published, no LegitScript or equivalent certification is displayed, and the weight-loss line is sold as prepaid three- and six-month packages rather than simple monthly plans, with the availability of a monthly option unclear from the public pages. The packages do bundle the telehealth visit, the medication and shipping, which is at least a clean, all-in structure once you are inside.

Pricing transparency

There is no published price for sermorelin, for NAD⁺, for glutathione or for testosterone, so we are not quoting one — and unusually for this board, there is no adjacent GLP-1 figure to be tempted by either, because the weight line is gated too. The single number the site shows is a $179 starting offer attached to weight-loss initiation, described as including a free consultation, custom dosing, GLP-1 medication and delivery. That is a weight-loss entry price and tells you nothing about the longevity or hormone lines. The structural point to take into any consultation is the packaging: GLP-1 treatment is sold as prepaid three- and six-month blocks, so ask early whether the peptide and hormone lines are billed the same way, what the monthly equivalent is, whether a monthly option exists at all, and what happens to an unused balance if you stop. Refund terms are not stated publicly.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. ElleS states plainly that its compounded medications are tailored to patients and made in licensed US facilities, and that medications may be fulfilled by licensed pharmacies — but it names no pharmacy, and compounded sterile products are not reviewed by FDA for purity and potency the way approved drugs are. On the evidence, the longevity line spans two very different tiers and the site does not distinguish them. Sermorelin acts on the growth-hormone axis, a real and well-described mechanism, but the long-term human outcome data stays thin and no controlled trial demonstrates the body-composition or recovery results the category is sold on. NAD⁺ delivered by nasal spray is one of the routes with no controlled human outcome trials at all — the forms with human data are the oral precursors NR and NMN, and what they show is a raised blood NAD⁺ level rather than a demonstrated clinical outcome. Glutathione has essentially no controlled human outcome evidence either. Testosterone therapy is the exception with a real evidence base, and it comes with real obligations: it requires ongoing haematocrit, PSA and lipid monitoring and it suppresses fertility, so settle the monitoring schedule before starting. On the GLP-1 side, oral compounded capsules have no FDA-approved compounded counterpart and their bioavailability profile differs from the injectables studied in the brand trials. Individual results vary.

Pros and watch-outs

The evidence behind what ElleS prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• Sermorelin: a real GHRH drug, read against the anti-aging pitch

  An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

• Glutathione: the master antioxidant, and where the evidence actually is

  Oral glutathione really does raise your body stores (a 6-month RCT proved it) — but the longevity and detox claims are unproven, skin-lightening is modest, and IV glutathione is the most marketed, least evidenced route. The precursors may be the smarter bet.

• TRT: what testosterone therapy is actually proven to do

  An FDA-approved therapy for diagnosed hypogonadism — with real but moderate benefits (sexual function, mood; not vitality), cardiovascular non-inferiority in TRAVERSE, and a real fertility trade-off.

How ElleS compares

A few alternatives worth a look, depending on what you’re optimizing for.

• LHLuvo Health

  Prescription NAD⁺ as an injection, drops or nasal spray at one flat price

  See Luvo Health →
• Telos RX

  Choice of GLP-1 formats, including needle-free sublingual tirzepatide

  See Telos RX →
• SLSystem Labs

  NAD⁺ bundled with glutathione, B-12 and sermorelin from one service

  See System Labs →